The effects of levodopa and haloperidol on flash and pattern ERGs and VEPs in normal humans
โ Scribed by Peter Bartel; Marie Blom; Elna Robinson; Cees Meyden; Klerk Sommers; Pieter Becker
- Publisher
- Springer-Verlag
- Year
- 1990
- Tongue
- English
- Weight
- 412 KB
- Volume
- 76
- Category
- Article
- ISSN
- 0012-4486
No coin nor oath required. For personal study only.
โฆ Synopsis
We investigated the effects of single doses of the dopamine agonist levodopa and the dopamine antagonist haloperidol on pattern and flash electroretinograms (ERGs) and visual evoked potentials (VEPs) in normal subjects. A placebo and two treatment regimens were administered in a randomized double-masked design. No significant intertreatment differences in the pattern ERGs and VEPs were noted. Although not statistically significant, a clearly discernible tendency was found for increased flash ERG b-wave amplitudes after levodopa administration compared with placebo. In comparison with placebo and levodopa, haloperidol was associated with significantly prolonged flash ERG b-wave implicit times, including each oscillatory potential, which also showed increased duration, particularly in the O1-O3 interpeak implicit time. The failure of pattern ERGs and VEPs to show changes after haloperidol may have been related to the timing of the recordings, which took place during the presumed phase of rising blood levels and before the flash ERG and VEP recordings. Our findings further demonstrated the reliability of the flash ERG in revealing changes in dopaminergic status in the visual system and suggest that steady-state (flicker) ERGs, cone ERGs, and oscillatory potentials have particular use in this regard.
๐ SIMILAR VOLUMES
An attempt was made to evaluate tranquilizing effects of three neuroleptic drugs (10 and 50 mg melperone, 1 mg haloperidol, and 50 mg chlorpromazine) and diazepam (10 mg) on experimental anxiety in normal subjects. This was done by studying the effects of the drugs on the anticipatory autonomic (ski
## Abstract We performed a detailed evaluation of pulmonary function in 53 patients with idiopathic Parkinson's disease (PD) who did not have symptoms of pulmonary or cardiac dysfunction. There was a significant pulmonary dysfunction of restrictive type which partially responded to levodopa. Compar